抑制UNC13B通过抑制多发性骨髓瘤中亡途径来抑制细胞增殖
Yuan Tao1, Lihua Yuan2, Yuntian Ding3
1Department of Hematology, The Affiliated Panyu Central Hospital of Guangzhou Medical University, 8 Fuyu East Road, Panyu, Guangzhou 511400, China.
UNC13B支持多发性骨髓瘤 (MM) 细胞的存活和增殖. 准UNC13B可能为治疗这种血液性恶性瘤提供了一个新的治疗策略.
科学领域:
- 血液学恶性瘤研究研究
- 癌症生物学 癌症生物学
- 分子瘤学分子瘤学
背景情况:
- 多发性骨髓瘤 (MM) 是一种复杂的血液性恶性瘤,具有异质的发病因子,仍然无法治愈.
- 在癌症生物学中,UNC13B (unc-13同位素B) 是一种前突触蛋白质,其作用在很大程度上未被描述.
- 之前的研究已经探索了UNC13B在神经疾病中的功能,但其在癌症中的参与仍然不清楚.
研究的目的:
- 研究UNC13B在调节多发性骨髓瘤细胞增殖中的作用.
- 确定UNC13B对多发性骨髓瘤细胞亡的影响.
- 阐明UNC13B影响MM病变的分子机制.
主要方法:
- 在人类MM细胞系中评估了UNC13BmRNA表达.
- 在ARD细胞中使用了用于UNC13B特异的shRNA转导的lentiviral载体.
- 评估了细胞增殖 (CCK-8检测),细胞亡 (流细胞计) 和蛋白质表达 (西部斑).
主要成果:
- 在多发性骨髓瘤细胞系中,UNC13B被显著上调.
- 击败UNC13B抑制了ARD细胞中的细胞增殖和诱导的细胞亡.
- 增殖和亡的变化与PINK1,CDK2,AKR7A3和Bim等关键蛋白质的调节相关.
结论:
- UNC13B促进多发性骨髓瘤细胞的存活和增殖.
- UNC13B可能调节MM的瘤和亡信号通路.
- UNC13B为多发性骨髓瘤治疗提供了一个潜在的新型治疗点.
更多相关视频
09:57Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
Published on: January 29, 2019
08:49Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
相关概念视频
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
Inhibition of Cdk Activity
The Extrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules
